Infection continues to be a major cause of morbidity and mortality in neutropenic patients
following chemotherapy or bone marrow transplantation (BMT). Concerted efforts have been
made to protect these patients from infection during the neutropenic period. Elaborate
protocols to protect the patient from both intrinsic and extrinsic pathogens have been
devised, ranging from simple single room isolation to laminar air flow units (LAFs), in
association with varying degrees of antibiotic decontamination of the digestive tract …